ezm logo
Partner With Merck

Partnering refers to the process of enabling one or more services to provide secure communication and collaboration between Merck and its external business partners.

EngageZone provides a secure and highly compartmentalized collaborative work environment for Merck and its worldwide business partners to exchange documents and to facilitate communications. Partners signing into EngageZone have controlled access and visibility to all their collaborations that use EngageZone in one place, regardless of which Merck business units they are working with.


At Merck, our clinical trials are designed, conducted and monitored in adherence to the same standards, whether they take place in the United States or elsewhere around the world. In conducting clinical trials, we also adhere to the guidelines of The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.

Merck-sponsored clinical trials in patients are registered on ClinicalTrials.gov, a service of the U.S. National Institutes of Health. Links to Merck sponsored clinical trials by phase are found in Explore our Pipeline. Information about ongoing clinical trials is also available online through the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).

Interested in Conducting Merck Clinical Trials?

Submit your profile to become a potential Clinical Trial Investigator for a Merck Clinical Trial. (US physicians only at this time)

Investigator Initiated Studies

The IIS Program consists of committees of medical and scientific staff from different therapeutic areas who meet to review investigator study proposals. Use this link if you are interested in learning more about the IIS Program.

Research Investigators

For all the original research we conduct at Merck, we know that the next great discovery in medicine may come from outside of our laboratories. This is why the formation of strategic partnerships is a central part of our mission to turn breakthrough science into novel medicines that improve patients' lives.

Flexibility, innovation and creativity are at the heart of the way we work with partners around the world. Our MRL scientists and licensing team works with partners to advance their science through drug discovery and development collaborations and licensing agreements that are mutually beneficial.

Interested in exploring research collaboration with Merck? Learn how we can work together to translate novel science to address unmet medical need.

Copyright © Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. | Privacy | Terms of Use